Abstract:The two coupling agents SPDP (N-succinimidyl-3-(2-pyridyldithio)propionate) and SATA (N-succinimidyl-S-acetylthioacetate) were compared in their efficiency and feasibility to couple monoclonal antibodies (Abs) via thioether linkage to liposomes functionalized by various lipophilic maleimide compounds like N-(3-maleimidopropionyl)-N2-palmitoyl-L-lysine methyl ester (MP-PL), N-(3-maleimidopropionyl)phosphatidylethanolamide (MP-PE), N6-(6-maleimidocaproyl)-N2-palmitoyl-L-lysine methyl ester (EMC-PL), and N-(6-maleimidocaproyl)phosphatidylethanolamine (EMC-PE). The composition of the liposomes was soy phosphatidylcholine (SPC), cholesterol, maleimide compounds and alpha-tocopherol (1:0.2:0.02:0.01, mol parts), plus N4-oleylcytosine arabinoside (NOAC) as cytostatic prodrug (0.2 mol parts) and a new, lipophilic and highly fluorescent dye N,N'-bis(1-hexylhfetyl)-3,4:9,10-perylenebis(dicarboximid ) (BHPD, 0.006 mol parts). From the maleimide derivatives MP-PL was the most effective in terms of preservation of the coupling activity in dependence of liposome storage. The coupling of the monoclonal A B8-24.3 (mouse IgG2b, MHC class I, anti H-2kb) and IB16-6 (rat IgG2a, anti B16 mouse melanoma) to the drug carrying liposomes was more effective and easier to accomplish with SATA as compared to SPDP. Coupling rates of 60-65% were obtained with SATA at molar ratios of 12 SATA:1 Ab:40 maleimide spacer groups on the surface of one liposome. The highest coupling rates with SPDP were obtained at the ratio of 24 SPDP:1 Ab:40 liposomal maleimide groups, with an Ab binding efficiency of only 20-25%. The optimal in vitro binding conditions to specific target cells (EL4 for B8-24.3-liposomes and B16-F10 for IB16-6-liposomes) were determined by cytofluorometric measurement of the liposomal BHPD fluorescence with SATA linked Abs. Optimal immunoliposome binding to specific epitopes on the target cells was achieved with 1-2 Ab molecules coupled to one liposome, with immunoliposome concentrations of 20-130 nM and with a small incubation volume of 0.3-0.4 ml. The specificity of the binding of B8-24.3-liposomes to EL4 target cells was visualized by scanning electron microscopy. Antibody mediated endocytic uptake of immunoliposomes could be demonstrated by transmission electron microscopy.

Preparation of Unilamellar Immunoliposomes by Passing Reversed Micelles Through Oil-water Interface.

Preparation of Low Molecular Weight Heparin Calcium Liposome Incubated by Chitosan and Determination of Encapsulation Efficiency

Immunoliposomes assemblied layer by layer from reverse micelles

Preparation of Immunoliposomes Encapsulating Alkaline Phosphatase

Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy

High throughput onion-like liposome formation with efficient protein encapsulation under flash antisolvent mixing

A Novel Method to Prepare Lipid Vesicles As Carrier of Hydrophilic Bioactive Substances

Preparation of Surface-Imprinted Microspheres Using Ionic Liquids As Novel Cross-Linker for Recognizing an Immunostimulating Peptide

Preparation Technology of Sinomenine Hydrochloride Liposomes

Preparation of Protein Imprinted Microspheres Using Amphiphilic Ionic Liquid As Stabilizer and Emulsifier Via Miniemulsion Polymerization

Preparation of Lysozyme Liposome

Preparation and Characterization of Trastuzumab Fab -Conjugated Liposomes (Immunoliposomes)

Preparation of lutein proliposomes by supercritical anti-solvent technique

Liquid Droplet-Mediated Formulation of Lipid Nanoparticles Encapsulating Immunoglobulin G for Cytosolic Delivery

Microfluidic production of liposomes through liquid-liquid phase separation in ternary droplets

Polyelectrolyte-coated liposomes microfluidically assembled in one-step for enhancing cell endocytosis and in-vivo immune responses

Studies on the Preparation Methods of Silybin Liposomes

Development of a Bifunctional Immunoliposome System for Combined Drug Delivery and Imaging in Vivo.

Building and Characterizing Antibody-Targeted Lipidic Nanotherapeutics.

Preparation and investigation of Ulex europaeus agglutinin I-conjugated liposomes as potential oral vaccine carriers

The preparation of targeted microbubble with low immunogenicity